Advanced search
Publication Cover
Leukemia & Lymphoma Volume 50, 2009 - Issue 2
Submit an article Journal homepage
133
Views
8
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Predicting durable remissions following thalidomide therapy for relapsed myeloma

Hang Quach Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Parkville, VIC, Australia
,
Linda Mileshkin Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Parkville, VIC, Australia
,
John F. Seymour Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Parkville, VIC, Australia
,
Alvin Milner Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia
,
David Ritchie Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Parkville, VIC, Australia
,
Simon Harrison Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia
,
David Westerman Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia
&
H. Miles Prince Division of Haematology and Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia; Department of Medicine, University of Melbourne, Parkville, VIC, AustraliaCorrespondence[email protected]
 show all
Pages 223-229 | Received 23 Aug 2008, Accepted 02 Dec 2008, Published online: 01 Jul 2009

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Philippe Moreau, Katja C. Weisel, Kevin W. Song, Craig J. Gibson, Owain Saunders, Lars Axel Sternas, Kevin Hong, Mohamed H. Zaki & Meletios A. Dimopoulos. (2016) Relationship of response and survival in patients with relapsed and refractory multiple myeloma treated with pomalidomide plus low-dose dexamethasone in the MM-003 trial randomized phase III trial (NIMBUS). Leukemia & Lymphoma 57:12, pages 2839-2847.
Read now
Hang Quach, H Miles Prince & Andrew Spencer. (2011) Managing multiple myeloma in the elderly: are we making progress?. Expert Review of Hematology 4:3, pages 301-315.
Read now

Articles from other publishers (6)

AP Dubey, Sameer Khatri, Sachin Maggo, Nilabh K Singh & Durgesh Sharma. (2021) Daratumumab Plus Carfilzomib: An Optimistic Approach in Relapsed/ Refractory Multiple Myeloma. Indian Journal of Medical and Paediatric Oncology 41:06, pages 846-849.
Crossref
Simon J. Harrison, Hang Quach, Emma Link, Huaibao Feng, Joanne Dean, Michael Copeman, Helgi Van De Velde, Anthony Schwarer, Bartrum Baker, Andrew Spencer, John Catalano, Philip Campbell, Bradley Augustson, Ken Romeril & Henry Miles Prince. (2015) The addition of dexamethasone to bortezomib for patients with relapsed multiple myeloma improves outcome but ongoing maintenance therapy has minimal benefit. American Journal of Hematology 90:5, pages E86-E91.
Crossref
Taxiarchis V. Kourelis, Shaji K. Kumar, Geetika Srivastava, Morie A. Gertz, Martha Q. Lacy, Francis K. Buadi, Suzanne R. Hayman, Steven R. Zeldenrust, Nelson Leung, Robert A. Kyle, Stephen J. Russell, David Dingli, John A. Lust, Yi Lin, Prashant Kapoor, Ronald Go, S. Vincent Rajkumar & Angela Dispenzieri. (2014) Long-term disease control in patients with newly diagnosed multiple myeloma after suspension of lenalidomide therapy. American Journal of Hematology 89:3, pages 302-305.
Crossref
S Lonial & K C Anderson. (2013) Association of response endpoints with survival outcomes in multiple myeloma. Leukemia 28:2, pages 258-268.
Crossref
Alessandra LaroccaVittorio MontefuscoSara BringhenDavide RossiClaudia CrippaRoberto MinaMonica GalliMagda MarcattiGiacinto La VerdeNicola GiulianiValeria MagarottoTommasina GuglielmelliDelia Rota-ScalabriniPaola OmedéAlberto SantagostinoIleana Baldi, Angelo Michele Carella, Mario BoccadoroPaolo CorradiniAntonio Palumbo. (2013) Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study. Blood 122:16, pages 2799-2806.
Crossref
Stephen A. Schey, Gareth J. Morgan, Karthik Ramasamy, Beth Hazel, Dariusz Ladon, Sophie Corderoy, Matthew Jenner, Karen Phekoo, Kevin Boyd & Faith E. Davies. (2010) The addition of cyclophosphamide to lenalidomide and dexamethasone in multiply relapsed/refractory myeloma patients; a phase I/II study. British Journal of Haematology 150:3, pages 326-333.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.